“Lebrikizumab Provides Progressive Improvements in Skin Clearance and Itch Relief Over One Year in Patients with Atopic Dermatitis”, J of Skin, vol. 7, no. 6, p. s278, Nov. 2023, doi: 10.25251/skin.7.supp.278.